{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:45:29Z","timestamp":1787240729735,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Parasitology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.exppara.2025.108898","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T02:32:10Z","timestamp":1736476330000},"page":"108898","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Ritonavir enhances the efficacy of amprenavir: A promising combination therapy by targeting Leishmania DNA topoisomerase I for treatment of visceral leishmaniasis"],"prefix":"10.1016","volume":"269","author":[{"given":"Priyanka H.","family":"Mazire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Snehal","family":"Shingade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exppara.2025.108898_bib1","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1051\/parasite\/2019071","article-title":"Cell death in Leishmania","volume":"26","author":"Basmaciyan","year":"2019","journal-title":"Parasite"},{"key":"10.1016\/j.exppara.2025.108898_bib2","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1073\/pnas.92.9.3726","article-title":"Molecular and cytotoxic effects of camptothecin, a topoisomerase I inhibitor, on trypanosomes and Leishmania","volume":"92","author":"Bodley","year":"1995","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.exppara.2025.108898_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/0169-4758(96)10017-X","article-title":"Topoisomerases in kinetoplastids","volume":"12","author":"Burri","year":"1996","journal-title":"Parasitol. Today"},{"key":"10.1016\/j.exppara.2025.108898_bib4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0006-291X(88)80081-0","article-title":"Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani","volume":"152","author":"Chakraborty","year":"1988","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1\u20132","key":"10.1016\/j.exppara.2025.108898_bib5","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF03402104","article-title":"Dihydrobetulinic acid induces apoptosis in Leishmania donovani by targeting DNA topoisomerase I and II: implications in antileishmanial therapy","volume":"9","author":"Chowdhury","year":"2003","journal-title":"Mol Med"},{"key":"10.1016\/j.exppara.2025.108898_bib6","first-page":"81","article-title":"Reconstitution and functional characterization of the unusual bi-subunit type I DNA topoisomerase from Leishmania donovani","volume":"565","author":"Das","year":"2004","journal-title":"FEBS Lett."},{"key":"10.1016\/j.exppara.2025.108898_bib7","doi-asserted-by":"crossref","first-page":"95","DOI":"10.3389\/fcimb.2012.00095","article-title":"Programmed cell death in Leishmania: biochemical evidence and role in parasite infectivity","volume":"2","author":"Gannavaram","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"1","key":"10.1016\/j.exppara.2025.108898_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1021\/acsinfecdis.2c00562","article-title":"Holanamine, a steroidal alkaloid from the bark of holarrhena pubescens wall. Ex G. Don inhibits the growth of Leishmania donovani by targeting DNA topoisomerase 1B","volume":"9","author":"Goel","year":"2023","journal-title":"ACS Infect. Dis."},{"issue":"3","key":"10.1016\/j.exppara.2025.108898_bib9","doi-asserted-by":"crossref","first-page":"e642","DOI":"10.1371\/journal.pntd.0000642","article-title":"Nelfinavir, an HIV-1 protease inhibitor, induces oxidative stress\u2013mediated, caspase-independent apoptosis in Leishmania amastigotes","volume":"4","author":"Kumar","year":"2010","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.exppara.2025.108898_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2022.115158","article-title":"DNA topoisomerases in the unicellular protozoan parasites: unwinding the mystery","volume":"203","author":"Lamba","year":"2022","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.exppara.2025.108898_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1179\/000349803225002516","article-title":"HIV and the transmission of Leishmania","volume":"97","author":"Molina","year":"2003","journal-title":"Ann. Trop. Med. Parasitol."},{"issue":"27","key":"10.1016\/j.exppara.2025.108898_bib12","doi-asserted-by":"crossref","first-page":"24717","DOI":"10.1074\/jbc.M201961200","article-title":"Increase in cytosolic Ca2+ levels through the activation of non-selective cation channels induced by oxidative stress causes mitochondrial depolarization leading to apoptosis-like death in Leishmania donovani promastigotes","volume":"277","author":"Mukherjee","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.exppara.2025.108898_bib13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1007\/s40121-024-00959-6","article-title":"Ritonavir: 25 Years' experience of concomitant medication management. A narrative review","volume":"13","author":"Quercia","year":"2024","journal-title":"Infect. Dis. Ther."},{"key":"10.1016\/j.exppara.2025.108898_bib14","article-title":"Miltefosine-Lopinavir Combination Therapy against Leishmania infantum infection: in vitro and in vivo approaches","volume":"9","author":"Rebello","year":"2019","journal-title":"Cell. Infect. Microbiol."},{"key":"10.1016\/j.exppara.2025.108898_bib15","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1017\/S0031182018000823","article-title":"Lopinavir, an HIV-1 peptidase inhibitor, induces alteration on the lipid metabolism of Leishmania amazonensis promastigotes","volume":"145","author":"Rebello","year":"2018","journal-title":"Parasitology"},{"key":"10.1016\/j.exppara.2025.108898_bib16","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1042\/BJ20071286","article-title":"An insight into the mechanism of inhibition of unusual bi-subunit topoisomerase I from Leishmania donovani by 3,3'-di-indolylmethane, a novel DNA topoisomerase I poison with a strong binding affinity to the enzyme","volume":"409","author":"Roy","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.exppara.2025.108898_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.parint.2021.102287","article-title":"The HIV-1 protease inhibitor Amprenavir targets Leishmania donovani topoisomerase I and induces oxidative stress-mediated programmed cell death","volume":"82","author":"Roy","year":"2021","journal-title":"Parasitol. Int."},{"issue":"5","key":"10.1016\/j.exppara.2025.108898_bib18","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1124\/mol.108.050161","article-title":"Mitochondria dependent ROS-mediated programmed cell death (PCD) induced by 3,3\u2032 -diindolylmethane (DIM) through inhibition of FoF1-ATP synthase in unicellular protozoan parasite Leishmania donovani","volume":"74","author":"Roy","year":"2008","journal-title":"Mol. Pharmacol."},{"issue":"3","key":"10.1016\/j.exppara.2025.108898_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004918","article-title":"HIV aspartyl peptidase inhibitors interfere with cellular proliferation, ultrastructure and macrophage infection of Leishmania amazonensis","volume":"4","author":"Santos","year":"2009","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.exppara.2025.108898_bib20","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1038\/sj.cdd.4401435","article-title":"Camptothecin induced mitochondrial dysfunction leading to programmed cell death in unicellular hemoflagellate Leishmania donovani","volume":"11","author":"Sen","year":"2004","journal-title":"Cell Death Differ."},{"issue":"43","key":"10.1016\/j.exppara.2025.108898_bib21","doi-asserted-by":"crossref","first-page":"18422","DOI":"10.1073\/pnas.1010693107","article-title":"Structure and mechanism of the complex between cytochrome P4503A4 and ritonavir","volume":"26","author":"Sevrioukova","year":"2010","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"1","key":"10.1016\/j.exppara.2025.108898_bib22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.3390\/pharmacy12010030","article-title":"Review of leishmaniasis treatment: can we see the forest through the trees?","volume":"12","author":"Shmueli","year":"2024","journal-title":"Pharmacy (Basel)"},{"key":"10.1016\/j.exppara.2025.108898_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.exppara.2017.02.010","article-title":"Copper salisylaldoxime (CuSAL) imparts protective efficacy against visceral leishmaniasis by targeting Leishmania donovani topoisomerase IB","volume":"5","author":"Singh","year":"2017","journal-title":"Exp. Parasitol."},{"issue":"5","key":"10.1016\/j.exppara.2025.108898_bib24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/pathogens12050706","article-title":"Recent advances in chemotherapeutics for leishmaniasis: importance of the cellular biochemistry of the parasite and its molecular interaction with the host","volume":"12","author":"Singh","year":"2023","journal-title":"Pathogens"},{"issue":"10","key":"10.1016\/j.exppara.2025.108898_bib25","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.pt.2010.06.008","article-title":"Programmed cell death in unicellular parasites: a prerequisite for sustained infection?","volume":"26","author":"van Zandbergen","year":"2010","journal-title":"Trends Parasitol."}],"container-title":["Experimental Parasitology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489425000037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014489425000037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,23]],"date-time":"2025-02-23T18:25:29Z","timestamp":1740335129000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014489425000037"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":25,"alternative-id":["S0014489425000037"],"URL":"https:\/\/doi.org\/10.1016\/j.exppara.2025.108898","relation":{},"ISSN":["0014-4894"],"issn-type":[{"value":"0014-4894","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ritonavir enhances the efficacy of amprenavir: A promising combination therapy by targeting Leishmania DNA topoisomerase I for treatment of visceral leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"Experimental Parasitology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exppara.2025.108898","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108898"}}